Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > MFIC Corporation Appoints Vice President of Operations and Engineering

MFIC Corporation (OTCBB: MFIC) today announced the appointment of William J. Conroy as Vice President of Operations and Engineering. In this position, Mr. Conroy will have responsibility for the global operations of the Company's Microfluidics equipment business, including product design and engineering, production, quality assurance and quality control, and purchasing. In direct support of MFIC's quality initiative, Mr. Conroy will also assume responsibility for overall systems quality and reliability. Mr. Conroy will report directly to Michael C. Ferrara, Chief Executive Officer.

MFIC Corporation Appoints Vice President of Operations and Engineering

NEWTON, MA | Posted on March 25th, 2008

"Bill is an important addition to the MFIC management team and we
believe that the Company and our customers will greatly benefit from
his extensive experience," said Michael C. Ferrara. "Bill's proven
ability to create highly functioning, quality-driven operating units
and his strong innovation and leadership skills will play a critical
role in MFIC's global growth strategy."

"I'm pleased to be joining MFIC at such an important time in the
Company's history," said William J. Conroy. "I believe MFIC has
substantial opportunity for global growth and I look forward to
working with the team to build an operations organization that is
second to none in terms of innovation, quality and customer focus."

Mr. Conroy brings more than twenty-five years of high-tech product
management, quality control and operations experience to MFIC. Most
recently, he served as Senior Vice President of Production and
Operations at RemoteReality Corporation, which designs and
manufactures products for the military/defense and security business
sectors. Mr. Conroy has also held senior level operations,
manufacturing and quality control positions at Northrop Grumman
(formerly Fibersense Technology Corporation), Karl Storz Endovision,
Circon ACMI and Kohler Company.


About MFIC Corporation
MFIC Corporation, through its Microfluidics Division, designs,
manufactures and distributes proprietary high performance
Microfluidizer(R) materials processing and formulation equipment to
the biotechnology, pharmaceutical, chemical, cosmetics/personal care,
and food industries. MFIC applies its more than 20 years of high
pressure processing experience to produce the most uniform and
smallest liquid and suspended solid particles available, and has
provided manufacturing systems for nanoparticle products for more than
15 years.

The Company is a leader in advanced materials processing equipment
for laboratory, pilot scale and manufacturing applications, offering
innovative technology and comprehensive solutions for nanoparticles
and other materials processing and production. More than 3,000 systems
are in use and afford significant competitive and economic advantages
to MFIC equipment customers.

Forward Looking Statement:

Management believes that this release contains forward-looking
statements that are subject to certain risks and uncertainties
including statements relating to our plan to achieve, maintain and/or
increase growth in revenue and/or market share, to achieve, maintain,
and/or increase operating profitability, and/or to achieve, maintain,
and/or increase net operating profitability. Such statements are based
on our current expectations and are subject to a number of factors and
uncertainties that could cause actual results achieved by us to differ
materially from those described in the forward-looking statements. We
caution investors that there can be no assurance that the actual
results or business conditions will not differ materially from those
projected or suggested in such forward-looking statements as a result
of various factors, including but not limited to, the following risks
and uncertainties: (i) whether the performance advantages of our
Microfluidizer materials processing equipment will be realized
commercially or that a commercial market for the equipment will
continue to develop, (ii) whether the timing of orders will
significantly affect quarter to quarter revenues and resulting net
income results for a particular quarter, which may cause increased
volatility in our stock price, (iii) whether we will have access to
sufficient working capital through continued and improving cash flow
from sales and ongoing borrowing availability, the latter being
subject to our ability to maintain compliance with the covenants and
terms of our loan agreement with our senior lender, (iv) whether our
Microfluidics Reaction Technology will be adopted by customers as a
means of producing innovative materials in large quantities, (v)
whether we are able to deploy prototype Microfluidics Reaction
Technology systems for nanoparticle production and then manufacture
and introduce commercial production Microfluidics Reaction Technology
equipment, and (vi) whether we will achieve a greater proportion of
our sales in the future through the sale of advanced processor
production systems.

For more information, please click here

MFIC Corporation
Jack M. Swig

MacDougall Biomedical Communications
Sarah Cavanaugh

Copyright © MFIC Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

'Material universe' yields surprising new particle November 28th, 2015

Iranian Scientists Discover New Catalyst to Remove Pharmaceutical Compounds from Wastewater November 28th, 2015

RAMAN Spectrometry Makes Characterization of Various Nanostructures Possible November 28th, 2015

Nanoparticles Boost Impact Resistance of Special Type of Polymer November 28th, 2015


Monitoring critical blood levels in real time in the ICU: EPFL has developed a miniaturized microfluidic device that will allow medical staff to monitor in real time levels of glucose, lactate a.s.o. and react more quickly October 22nd, 2015

Chip-based technology enables reliable direct detection of Ebola virus: Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA September 26th, 2015

Smart hydrogel coating creates 'stick-slip' control of capillary action July 27th, 2015

Miniature Technology, Large-Scale Impact: Winner of the 2015 Lindros Award for translational medicine, Kjeld Janssen is pushing the boundaries of the emerging lab-on-a-chip technology July 7th, 2015


'Material universe' yields surprising new particle November 28th, 2015

Iranian Scientists Discover New Catalyst to Remove Pharmaceutical Compounds from Wastewater November 28th, 2015

RAMAN Spectrometry Makes Characterization of Various Nanostructures Possible November 28th, 2015

Nanoparticles Boost Impact Resistance of Special Type of Polymer November 28th, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Kerstin Kleese van Dam Named Director of Brookhaven Lab's Computational Science Initiative September 26th, 2015

QD Vision Names Display Industry Veteran Mustafa Ozgen as CEO to Support Aggressive Growth and Market Expansion September 15th, 2015

National Space Society Welcomes Janet Ivey As New NSS Governor: Janet Ivey of Janet's Planet is NOW IN ORBIT as a member of the Board of Governors of the National Space Society August 27th, 2015

National Space Society Welcomes Geoff Notkin As New NSS Governor August 26th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic